RIGL Stock Analysis: Buy, Sell, or Hold?
RIGL - Rigel Pharmaceuticals Inc. (New)
$48.97
0.09 (0.18%)
▲
5d:
+3.64%
30d:
+1.75%
90d:
+33.29%
BUY
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 03, 2026
11d
Get Alerted When RIGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RIGL shows positive signals but monitor for confirmation. Market pricing in 6.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: RIGL shows positive signals but monitor for confirmation. Market pricing in 6.4% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$78.87
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$48.97
0.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RIGL is currently trading at $48.97, which is considered extended relative to its 30-day fair value range of $46.10 to $48.78. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.9) compared to its historical average (8.2). At these levels, the market is pricing in 6.4% annual earnings growth.
Technical Outlook: Technically, RIGL is in a strong uptrend. Immediate support is located at $45.48, while resistance sits at $50.49.
Market Sentiment: RIGL scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $63.00 (+28.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RIGL is in a strong uptrend. Immediate support is located at $45.48, while resistance sits at $50.49.
Market Sentiment: RIGL scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $63.00 (+28.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$46.10 -
$48.78
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.9% below Wall St target ($63.00)
- BULLISH: Expecting earnings turnaround to 6.4% growth with -22.6% revenue growth
- BULLISH: Bottoming setup score 64/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$46.10 -
$48.78
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$4.53
(9.2%)
Support & Resistance Levels
Support Level
$45.48
Resistance Level
$50.49
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.90
Wall Street Target
$63.00
(+28.9%)
Revenue Growth (YoY)
-22.6%
Earnings Growth (YoY)
-73.2%
Profit Margin
116.3%
Valuation Premium vs History
+6.4% premium
PE vs Historical
9.9 vs 8.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.4%
(market-implied from PE analysis)
1-Year Target
$52.01
(+6%)
2-Year Target
$55.34
(+13%)
3-Year Target
$58.88
(+21%)
3-Yr Target (if PE normalizes)
(PE: 10→8)
PE COMPRESSION
$48.79
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 39.4%)
$265.83
(+444%)
Base:
(SPY PE: 9.9, Growth: 39.4%)
$132.46
(+171%)
Bear:
(PE: 8.2, Growth: 39.4%)
$109.76
(+125%)
📈
Valuation based on Current Earnings
Trailing PE: 2.77 | Current EPS (TTM): $17.36
Bull Case
$26.46
(-46%)
Analyst growth -50.0%, PE expands to 3.1
Base Case
$24.05
(-51%)
Market implied -50.0%, PE stable at 2.8
Bear Case
$32.71
(-33%)
Severe decline -20.0%, PE contracts to 2.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 9:27 AM ET
Data refreshes hourly during market hours. Next update: 10:27 AM
Data refreshes hourly during market hours. Next update: 10:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RIGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 47 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 71 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 50 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 63 BUY |
Advanced RIGL Option Strategies
Professional options setups generated by AI based on today's RIGL price and gamma walls.
